Gilead Sciences, Inc.
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.33−0.35 (-0.21%)
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Non-GAAP cost of goods sold by Year
Non-GAAP cost of goods sold ($M) ($M)
Gilead Sciences Non-GAAP cost of goods sold: $3,919M in FY2025, down 0.4% from a year earlier.
Latest, FY2025
3,919
Period ended Dec 31, 2025
Change on a year earlier
-0.4%
3,936 in FY2024
History
10 years
Since FY2016
Sources
9
Documents cited below
Where the FY2025 figure comes from
“|| Cost of goods sold | $ | 1,044 | $ | 1,002 | 4% | $ | 3,919 | $ | 3,936 | —%”
Source: Form 8-K (exhibit991earningspressrel.htm, filed 2026-02-10) ↗
Reported in Form 8-K GAAP to Non-GAAP Reconciliation.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP cost of goods sold ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3,919 | -0.4% | Form 8-K (exhibit991earningspressrel.htm, filed 2026-02-10) ↗ |
| FY2024 | Dec 31, 2024 | 3,936 | +6.5% | Form 8-K (exhibit991earningspressrel.htm, filed 2026-02-10) ↗ |
| FY2023 | Dec 31, 2023 | 3,697 | +2.6% | Form 8-K (exhibit991earningspressrel.htm, filed 2025-02-11) ↗ |
| FY2022 | Dec 31, 2022 | 3,602 | -20.6% | Form 8-K (exhibit991earningspressrel.htm, filed 2024-02-06) ↗ |
| FY2021 | Dec 31, 2021 | 4,538 | +37.8% | Form 8-K (exhibit991earningspressrel.htm, filed 2023-02-02) ↗ |
| FY2020 | Dec 31, 2020 | 3,294 | -8.2% | Form 8-K (exhibit991earningspressrel.htm, filed 2022-02-01) ↗ |
| FY2019 | Dec 31, 2019 | 3,587 | -0.1% | Form 8-K (exhibit991earningspressrel.htm, filed 2021-02-04) ↗ |
| FY2018 | Dec 31, 2018 | 3,590 | +4.9% | Form 8-K (exhibit991earningspres.htm, filed 2020-02-04) ↗ |
| FY2017 | Dec 31, 2017 | 3,422 | +0.2% | Form 8-K (exhibit991earningspressrel.htm, filed 2019-02-04) ↗ |
| FY2016 | Dec 31, 2016 | 3,414 | – | Form 8-K (gildq42017exh991.htm, filed 2018-02-06) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Non-GAAP cost of goods sold ($M), annual FY2016–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/ng-cogs
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.